Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143268 |
| CAS No | NA |
| Mol.F. | C28H44N4O7 |
| Mol.Wt. | 548.68 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143269 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143270 |
| CAS No | NA |
| Mol.F. | C16H20N2O3 |
| Mol.Wt. | 288.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143271 |
| CAS No | NA |
| Mol.F. | C7H5ClN4O5S2 |
| Mol.Wt. | 324.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143272 |
| CAS No | NA |
| Mol.F. | C9H8N2O3 |
| Mol.Wt. | 192.17g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143273 |
| CAS No | NA |
| Mol.F. | C20H33N3O6 |
| Mol.Wt. | 411.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143274 |
| CAS No | NA |
| Mol.F. | C9H14N2O3 |
| Mol.Wt. | 198.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143275 |
| CAS No | NA |
| Mol.F. | C16H20N2O3 |
| Mol.Wt. | 288.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143276 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O6S |
| Mol.Wt. | 428.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143277 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O5S |
| Mol.Wt. | 412.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143278 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O7S |
| Mol.Wt. | 444.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143279 |
| CAS No | NA |
| Mol.F. | C32H27F4N7O7S2 |
| Mol.Wt. | 761.72 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143280 |
| CAS No | NA |
| Mol.F. | C15H9F2N4O6 |
| Mol.Wt. | 379.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143281 |
| CAS No | NA |
| Mol.F. | C15H12F2N4O5S |
| Mol.Wt. | 398.34 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143282 |
| CAS No | NA |
| Mol.F. | C8H5F2N3O3 |
| Mol.Wt. | 229.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143283 |
| CAS No | NA |
| Mol.F. | C9H7F2N3O5 |
| Mol.Wt. | 275.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |